840 related articles for article (PubMed ID: 33781656)
1. The efficacy and safety of hydroxychloroquine (HCQ) in treatment of COVID19 -a systematic review and meta-analysis.
Choudhuri AH; Duggal S; Ahuja B; Biswas PS
Indian J Med Microbiol; 2021 Apr; 39(2):159-170. PubMed ID: 33781656
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: A systematic review and meta-analysis.
Kumar J; Jain S; Meena J; Yadav A
J Infect Chemother; 2021 Jun; 27(6):882-889. PubMed ID: 33678548
[TBL] [Abstract][Full Text] [Related]
3. A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment.
Ghazy RM; Almaghraby A; Shaaban R; Kamal A; Beshir H; Moursi A; Ramadan A; Taha SHN
Sci Rep; 2020 Dec; 10(1):22139. PubMed ID: 33335141
[TBL] [Abstract][Full Text] [Related]
4. The Outcome of Hydroxychloroquine in Patients Treated for COVID-19: Systematic Review and Meta-Analysis.
Ayele Mega T; Feyissa TM; Dessalegn Bosho D; Kumela Goro K; Zeleke Negera G
Can Respir J; 2020; 2020():4312519. PubMed ID: 33082891
[TBL] [Abstract][Full Text] [Related]
5. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
[TBL] [Abstract][Full Text] [Related]
6. Hydroxychloroquine use and progression or prognosis of COVID-19: a systematic review and meta-analysis.
Zang Y; Han X; He M; Shi J; Li Y
Naunyn Schmiedebergs Arch Pharmacol; 2021 Apr; 394(4):775-782. PubMed ID: 32892293
[TBL] [Abstract][Full Text] [Related]
7. Virological and clinical cure in COVID-19 patients treated with hydroxychloroquine: A systematic review and meta-analysis.
Sarma P; Kaur H; Kumar H; Mahendru D; Avti P; Bhattacharyya A; Prajapat M; Shekhar N; Kumar S; Singh R; Singh A; Dhibar DP; Prakash A; Medhi B
J Med Virol; 2020 Jul; 92(7):776-785. PubMed ID: 32297988
[TBL] [Abstract][Full Text] [Related]
8. Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis.
Fiolet T; Guihur A; Rebeaud ME; Mulot M; Peiffer-Smadja N; Mahamat-Saleh Y
Clin Microbiol Infect; 2021 Jan; 27(1):19-27. PubMed ID: 32860962
[TBL] [Abstract][Full Text] [Related]
9. Mortality, viral clearance, and other clinical outcomes of hydroxychloroquine in COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials.
Kashour Z; Kashour T; Gerberi D; Tleyjeh IM
Clin Transl Sci; 2021 May; 14(3):1101-1112. PubMed ID: 33606894
[TBL] [Abstract][Full Text] [Related]
10. Systematic review and meta-analysis of the effectiveness and safety of hydroxychloroquine in treating COVID-19 patients.
Yang TH; Chou CY; Yang YF; Chien CS; Yarmishyn AA; Yang TY; Liu CH; Chang KJ; Yang YP; Chang YL
J Chin Med Assoc; 2021 Feb; 84(2):233-241. PubMed ID: 32947506
[TBL] [Abstract][Full Text] [Related]
11. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of hydroxychloroquine as pre-and post-exposure prophylaxis and treatment of COVID-19: A systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials.
Martins-Filho PR; Ferreira LC; Heimfarth L; Araújo AAS; Quintans-Júnior LJ
Lancet Reg Health Am; 2021 Oct; 2():100062. PubMed ID: 34485970
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis.
Kashour Z; Riaz M; Garbati MA; AlDosary O; Tlayjeh H; Gerberi D; Murad MH; Sohail MR; Kashour T; Tleyjeh IM
J Antimicrob Chemother; 2021 Jan; 76(1):30-42. PubMed ID: 33031488
[TBL] [Abstract][Full Text] [Related]
15. Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis.
Elavarasi A; Prasad M; Seth T; Sahoo RK; Madan K; Nischal N; Soneja M; Sharma A; Maulik SK; Shalimar ; Garg P
J Gen Intern Med; 2020 Nov; 35(11):3308-3314. PubMed ID: 32885373
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.
de Barros CM; Almeida CAF; Pereira B; Costa KCM; Pinheiro FA; Maia LDB; Trindade CM; Garcia RCT; Torres LH; Diwan S; Boralli VB
Pain Physician; 2020 Aug; 23(4S):S351-S366. PubMed ID: 32942793
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: A meta-review of systematic reviews and an updated meta-analysis.
Chivese T; Musa OAH; Hindy G; Al-Wattary N; Badran S; Soliman N; Aboughalia ATM; Matizanadzo JT; Emara MM; Thalib L; Doi SAR
Travel Med Infect Dis; 2021; 43():102135. PubMed ID: 34265436
[TBL] [Abstract][Full Text] [Related]
18. Pharmacoepidemiology, Machine Learning, and COVID-19: An Intent-to-Treat Analysis of Hydroxychloroquine, With or Without Azithromycin, and COVID-19 Outcomes Among Hospitalized US Veterans.
Gerlovin H; Posner DC; Ho YL; Rentsch CT; Tate JP; King JT; Kurgansky KE; Danciu I; Costa L; Linares FA; Goethert ID; Jacobson DA; Freiberg MS; Begoli E; Muralidhar S; Ramoni RB; Tourassi G; Gaziano JM; Justice AC; Gagnon DR; Cho K
Am J Epidemiol; 2021 Nov; 190(11):2405-2419. PubMed ID: 34165150
[TBL] [Abstract][Full Text] [Related]
19. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
20. The Role of Hydroxychloroquine in COVID-19: A Systematic Review and Meta-Analysis.
Shamshirian A; Hessami A; Heydari K; Navaei RA; Ebrahimzadeh MA; Yip GW; Ghasemian R; Sedaghat M; Baradaran H; Yazdi SM; Aboufazeli E; Jafarpour H; Dadgostar E; Tirandazi B; Sadeghnezhad R; Karimifar K; Eftekhari A; Shamshirian D
Ann Acad Med Singap; 2020 Oct; 49(10):789-800. PubMed ID: 33283842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
